Ovia Pharma Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 5.00 M
- Company Age 14 Year, 4 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth 23.34%
- Profit Growth 38.40%
- Ebitda 26.14%
- Net Worth 1.69%
- Total Assets 1.27%
About Ovia Pharma
Ovia Pharma Private Limited (OPPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 September 2010 and has a history of 14 years and four months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M, as per Ministry of Corporate Affairs (MCA) records.
Nandita Bajpai, Naveen Agrawal, Poonam Agrawal, and Two other members serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51909DL2010PTC208952
- Company No.
208952
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Sep 2010
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Ovia Pharma Private Limited offer?
Ovia Pharma Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Nutritional Supplements, Body Care Products, Body Lotions, Beverages Mixes, Energy Drink, Skin Creams, Beauty Cream, Multivitamin Syrup & Drops, Multivitamin Drops.
Who are the key members and board of directors at Ovia Pharma?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nandita Bajpai  | Director | 26-Oct-2012 | Current |
| Naveen Agrawal | Director | 15-Apr-2016 | Current |
| Poonam Agrawal | Director | 25-May-2016 | Current |
| Pulkit Modi | Director | 22-Nov-2017 | Current |
| Ashish Bajpai | Director | 05-Feb-2011 | Current |
Financial Performance of Ovia Pharma.
Ovia Pharma Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 23.34% increase. The company also saw a substantial improvement in profitability, with a 38.4% increase in profit. The company's net worth moved up by a moderate rise of 1.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ovia Pharma?
In 2020, Ovia Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ovia Pharma Life Private LimitedNaveen Agrawal and Poonam Agrawal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ovia Pharma?
Unlock and access historical data on people associated with Ovia Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ovia Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ovia Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
